These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19923351)

  • 1. Interleukin 2 targeted therapy in inflammatory bowel disease.
    Yarkoni S; Sagiv Y; Kaminitz A; Askenasy N
    Gut; 2009 Dec; 58(12):1705-6. PubMed ID: 19923351
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical therapy of inflammatory bowel disease.
    Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):xv-xvi. PubMed ID: 15177548
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppresive therapy for inflammatory bowel disease.
    Casis Herce B
    Rev Esp Enferm Dig; 2003 Jul; 95(7):456-8, 453-5. PubMed ID: 12952507
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease.
    Barta Z; Zöld E; Zeher M
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1363-4; author reply 1364. PubMed ID: 17509104
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of cyclosporine therapy in inflammatory bowel disease.
    Cullen G; Keegan D; O'Donoghue D
    Am J Gastroenterol; 2008 Oct; 103(10):2654-5; author reply 2655. PubMed ID: 18855861
    [No Abstract]   [Full Text] [Related]  

  • 6. Current drug therapy for inflammatory bowel disease.
    Ogorek CP; Fisher RS
    Compr Ther; 1991 Apr; 17(4):31-7. PubMed ID: 1879116
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease.
    Roblin X; Phelip JM
    Arch Intern Med; 2008 Mar; 168(6):667; author reply 667-8. PubMed ID: 18362263
    [No Abstract]   [Full Text] [Related]  

  • 8. Are we ready for top-down therapy for inflammatory bowel diseases: con.
    Herfarth H
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):249-55. PubMed ID: 19072417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.
    Atreya I; Neurath MF
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):23-34. PubMed ID: 19072367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the use of non-biologic agents in the treatment of inflammatory bowel diseases].
    Bosques Padilla F
    Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():86-90. PubMed ID: 17037785
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory bowel disease in exclusively breast-fed infants.
    Kuloğlu Z; Kansu A; Kirsaçlioğlu C; Ince E; Ensari A; Girgin N
    Scand J Gastroenterol; 2006 Nov; 41(11):1364-7. PubMed ID: 17060132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conventional and immunomodulatory therapy in chronic inflammatory bowel diseases].
    Marth T; Zeitz M
    Dtsch Med Wochenschr; 1999 Oct; 124(40):1173-7. PubMed ID: 10548948
    [No Abstract]   [Full Text] [Related]  

  • 13. Current and future therapies for inflammatory bowel disease.
    Zisman TL; Kane SV
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):89-100. PubMed ID: 19072438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the delayed onset of action of azathioprine in IBD: are we there yet?
    Atreya I; Neurath MF
    Gut; 2009 Mar; 58(3):325-6. PubMed ID: 19211850
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-stop progress in inflammatory bowel disease: new players, new understanding, new therapies.
    Fiocchi C
    Curr Opin Gastroenterol; 2006 Jul; 22(4):347-8. PubMed ID: 16760747
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammatory bowel disease and infection concerns.
    Mayo Clin Health Lett; 2008 Aug; 26(8):4. PubMed ID: 18802973
    [No Abstract]   [Full Text] [Related]  

  • 17. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of immunosuppressive drugs in IBD: RAND or random choice?
    Vermeire S
    Dig Liver Dis; 2005 Jun; 37(6):391-3. PubMed ID: 15893276
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatosplenic T cell lymphoma in inflammatory bowel disease.
    Shale M; Kanfer E; Panaccione R; Ghosh S
    Gut; 2008 Dec; 57(12):1639-41. PubMed ID: 18667489
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.